Zebrafish patient-derived xenograft models predict lymph node involvement and treatment outcome in non-small cell lung cancer.
Zaheer AliMalin VildevallGabriela Vazquez RodriguezDecky TandionoIoannis VamvakarisGeorgios EvangelouGeorgios LolasKonstantinos N SyrigosAlberto VillanuevaMichael WickShenga OmarAnna ErkstamJulia SchuelerAnna FahlgrenLasse D JensenPublished in: Journal of experimental & clinical cancer research : CR (2022)
We conclude that the ZTX platform provide a fast, accurate, and clinically relevant system for evaluation of treatment outcome and invasion/dissemination of PDX models, providing an attractive platform for combined mouse-zebrafish PDX trials and personalized medicine.